10X Genomics accuses Bio-Rad of monopolizing markets for genetic analysis
MLex Summary: 10X Genomics filed antitrust counterclaims accusing Bio-Rad Laboratories of illegally monopolizing multiple markets related to genetic analysis through its acquisition of competitor RainDance. Bio-Rad Laboratories filed a case accusing...To view the full article, register now.
Already a subscriber? Click here to view full article